These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8393404)

  • 1. Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study.
    Kubota K; Yamada S; Ishiwata K; Ito M; Fujiwara T; Fukuda H; Tada M; Ido T
    Eur J Nucl Med; 1993 Jun; 20(6):495-501. PubMed ID: 8393404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
    Masarykova A; Scepanovic D; Povinec P; Bires P; Lederleitner D; Pobijakova M
    Bratisl Lek Listy; 2018; 119(3):133-138. PubMed ID: 29536740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer.
    Kubota K; Yamada S; Ishiwata K; Ito M; Ido T
    Clin Nucl Med; 1992 Nov; 17(11):877-81. PubMed ID: 1330395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of 201Tl SPECT in the evaluation of treatment effect for primary lung cancer].
    Yamaji S
    Kaku Igaku; 1995 Dec; 32(12):1333-40. PubMed ID: 8587215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung tumor imaging by positron emission tomography using C-11 L-methionine.
    Kubota K; Matsuzawa T; Ito M; Ito K; Fujiwara T; Abe Y; Yoshioka S; Fukuda H; Hatazawa J; Iwata R
    J Nucl Med; 1985 Jan; 26(1):37-42. PubMed ID: 2981300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography.
    Fujiwara T; Matsuzawa T; Kubota K; Abe Y; Itoh M; Fukuda H; Hatazawa J; Yoshioka S; Yamaguchi K; Ito K
    J Nucl Med; 1989 Jan; 30(1):33-7. PubMed ID: 2536082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
    Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
    Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
    Bury T; Corhay JL; Duysinx B; Daenen F; Ghaye B; Barthelemy N; Rigo P; Bartsch P
    Eur Respir J; 1999 Dec; 14(6):1376-80. PubMed ID: 10624770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.
    Lilja A; Lundqvist H; Olsson Y; Spännare B; Gullberg P; Långström B
    Acta Radiol; 1989; 30(2):121-8. PubMed ID: 2493795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine.
    Lindholm P; Leskinen-Kallio S; Grénman R; Lehikoinen P; Någren K; Teräs M; Ruotsalainen U; Joensuu H
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):787-94. PubMed ID: 7790265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of solitary pulmonary nodules with positron emission tomography using [11C]L-methionine.
    Kubota K; Matsuzawa T; Fujiwara T; Abe Y; Ito M; Hatazawa J; Ido T; Ishiwata K; Watanuki S
    J Comput Assist Tomogr; 1988; 12(5):794-6. PubMed ID: 3262634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography.
    Pieterman R; Willemsen A; Appel M; Pruim J; Koëter G; Vaalburg W; Groen H
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):243-7. PubMed ID: 11926387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
    Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
    J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer.
    Koizumi M; Saga T; Yoshikawa K; Suzuki K; Yamada S; Hasebe M; Ohashi S; Abd-Elrazek S; Ishikawa H; Sagou K; Tamura K; Hara R; Kato H; Yasuda S; Yanagi T; Tsujii H
    Mol Imaging Biol; 2008; 10(6):374-80. PubMed ID: 18679757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positron emission tomography of lung cancer using 18F-2-fluoro-2-deoxy-D-glucose and L-[11C-methyl]-methionine].
    Matsuzawa T; Fujiwara T; Abe Y; Itoh M; Fukuda H; Yamaguchi K; Kawai H; Kubota K; Yamaguchi T; Miyazawa H
    Kokyu To Junkan; 1987 Jan; 35(1):15-20. PubMed ID: 3031787
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.